ORCID as entered in ROS

Select Publications
1997, 'Human leukocyte antigens and natural selection by malaria', in Infection, Polymorphism and Evolution, Springer Netherlands, pp. 109 - 115, http://dx.doi.org/10.1007/978-94-009-0077-6_12
,1996, 'The MHC in Host-Pathogen Evolution', in MHC Molecules: Expression, Assembly and Function, Springer US, pp. 243 - 260, http://dx.doi.org/10.1007/978-1-4684-6462-7_15
,2025, 'Bivalent mRNA booster vaccination recalls cellular and antibody immunity against antigenically divergent SARS-CoV-2 spike antigens', Npj Vaccines, 10, pp. 74, http://dx.doi.org/10.1038/s41541-025-01129-6
,2025, 'High frequency CCR5 editing in human hematopoietic stem progenitor cells protects xenograft mice from HIV infection', Nature Communications, 16, pp. 446, http://dx.doi.org/10.1038/s41467-025-55873-3
,2025, 'Binding antibody titers against the hemagglutinin and neuraminidase correlate with protection against medically attended influenza A and B disease.', J Virol, pp. e0039125, http://dx.doi.org/10.1128/jvi.00391-25
,2025, 'Randomized trial of same- versus opposite-arm coadministration of inactivated influenza and SARS-CoV-2 mRNA vaccines', Jci Insight, 10, pp. e187075, http://dx.doi.org/10.1172/jci.insight.187075
,2025, 'Optimisation of a multiplexed, high throughput assay to measure neutralising antibodies against SARS-CoV-2 variants', Journal of Virological Methods, 332, pp. 115073, http://dx.doi.org/10.1016/j.jviromet.2024.115073
,2025, 'Macrophages direct location-dependent recall of B cell memory to vaccination', Cell, pp. S0092-8674(25)00407-6, http://dx.doi.org/10.1016/j.cell.2025.04.005
,2025, 'Towards evidence-based immunology', Nature Immunology, http://dx.doi.org/10.1038/s41590-025-02180-0
,2024, 'Defining the correlates of lymphopenia and independent predictors of poor clinical outcome in adults hospitalized with COVID-19 in Australia', Scientific Reports, 14, pp. 11102, http://dx.doi.org/10.1038/s41598-024-61729-5
,2024, 'Predicting COVID-19 booster immunogenicity against future SARS-CoV-2 variants and the benefits of vaccine updates', Nature Communications, 15, pp. 8395, http://dx.doi.org/10.1038/s41467-024-52194-9
,2024, 'Predicting vaccine effectiveness for mpox', Nature Communications, 15, pp. 3856, http://dx.doi.org/10.1038/s41467-024-48180-w
,2024, 'Blood Distribution of SARS-CoV-2 Lipid Nanoparticle mRNA Vaccine in Humans', ACS Nano, 18, pp. 27077 - 27089, http://dx.doi.org/10.1021/acsnano.4c11652
,2024, 'Randomized controlled trial reveals no benefit to a 3-month delay in COVID-19 mRNA booster vaccine', Journal of Clinical Investigation, 134, pp. e181244, http://dx.doi.org/10.1172/JCI181244
,2024, 'B-cell characteristics define HCV reinfection outcome', Journal of Hepatology, 81, pp. 415 - 428, http://dx.doi.org/10.1016/j.jhep.2024.04.004
,2024, 'Impact of alemtuzumab-mediated lymphocyte depletion on SIV reservoir establishment and persistence', Plos Pathogens, 20, pp. e1012496, http://dx.doi.org/10.1371/journal.ppat.1012496
,2024, 'Viral clearance as a surrogate of clinical efficacy for COVID-19 therapies in outpatients: a systematic review and meta-analysis', Lancet Microbe, 5, pp. e459 - e467, http://dx.doi.org/10.1016/S2666-5247(23)00398-1
,2024, 'Early antiretroviral therapy in SIV-infected rhesus macaques reveals a multiphasic, saturable dynamic accumulation of the rebound competent viral reservoir', Plos Pathogens, 20, pp. e1012135, http://dx.doi.org/10.1371/journal.ppat.1012135
,2024, 'The gene regulatory basis of bystander activation in CD8+ T cells', Science Immunology, 9, pp. eadf8776, http://dx.doi.org/10.1126/sciimmunol.adf8776
,2024, 'Mucosal and systemic immune correlates of viral control after SARS-CoV-2 infection challenge in seronegative adults', Science Immunology, 9, pp. eadj9285, http://dx.doi.org/10.1126/sciimmunol.adj9285
,2024, 'Immunoglobulin G genetic variation can confound assessment of antibody levels via altered binding to detection reagents', Clinical and Translational Immunology, 13, pp. e1494, http://dx.doi.org/10.1002/cti2.1494
,2023, 'Evidence for exposure dependent carriage of malaria parasites across the dry season: modelling analysis of longitudinal data', Malaria Journal, 22, http://dx.doi.org/10.1186/s12936-023-04461-1
,2023, 'Monoclonal antibody levels and protection from COVID-19', Nature Communications, 14, pp. 4545, http://dx.doi.org/10.1038/s41467-023-40204-1
,2023, 'Predicting vaccine effectiveness against severe COVID-19 over time and against variants: a meta-analysis', Nature Communications, 14, pp. 1633, http://dx.doi.org/10.1038/s41467-023-37176-7
,2023, 'Determinants of passive antibody efficacy in SARS-CoV-2 infection: a systematic review and meta-analysis', Lancet Microbe, 4, pp. e883 - e892, http://dx.doi.org/10.1016/S2666-5247(23)00194-5
,2023, 'Mucosal antibody responses following Vaxzevria vaccination', Immunology and Cell Biology, 101, pp. 975 - 983, http://dx.doi.org/10.1111/imcb.12685
,2023, 'Preferential selection of viral escape mutants by CD8+ T cell 'sieving' of SIV reactivation from latency', Plos Pathogens, 19, pp. e1011755, http://dx.doi.org/10.1371/journal.ppat.1011755
,2023, 'Timing of initiation of anti-retroviral therapy predicts post-treatment control of SIV replication', Plos Pathogens, 19, pp. e1011660, http://dx.doi.org/10.1371/journal.ppat.1011660
,2023, 'Systemic host inflammation induces stage-specific transcriptomic modification and slower maturation in malaria parasites', Mbio, 14, pp. e0112923, http://dx.doi.org/10.1128/mbio.01129-23
,2023, 'Adaptation of a transmitted/founder simian-human immunodeficiency virus for enhanced replication in rhesus macaques', Plos Pathogens, 19, pp. e1011059, http://dx.doi.org/10.1371/journal.ppat.1011059
,2023, 'Durable reprogramming of neutralizing antibody responses following Omicron breakthrough infection', Science Advances, 9, pp. eadg5301, http://dx.doi.org/10.1126/sciadv.adg5301
,2023, 'Robust and prototypical immune responses toward COVID-19 vaccine in First Nations peoples are impacted by comorbidities', Nature Immunology, 24, pp. 966 - 978, http://dx.doi.org/10.1038/s41590-023-01508-y
,2023, 'SARS-CoV-2 breakthrough infection induces rapid memory and de novo T cell responses', Immunity, 56, pp. 879 - 892.e4, http://dx.doi.org/10.1016/j.immuni.2023.02.017
,2023, 'Predicting the efficacy of variant-modified COVID-19 vaccine boosters', Nature Medicine, 29, pp. 574 - 578, http://dx.doi.org/10.1038/s41591-023-02228-4
,2023, 'Correlates of Protection, Thresholds of Protection, and Immunobridging among Persons with SARS-CoV-2 Infection', Emerging Infectious Diseases, 29, pp. 381 - 388, http://dx.doi.org/10.3201/eid2902.221422
,2023, 'CD8+ lymphocytes do not impact SIV reservoir establishment under ART', Nature Microbiology, 8, pp. 299 - 308, http://dx.doi.org/10.1038/s41564-022-01311-9
,2023, 'Immune profiling of SARS-CoV-2 infection during pregnancy reveals NK cell and γδ T cell perturbations', Jci Insight, 8, pp. e167157, http://dx.doi.org/10.1172/jci.insight.167157
,2023, 'Preexisting immunity restricts mucosal antibody recognition of SARS-CoV-2 and Fc profiles during breakthrough infections', JCI Insight, 8, pp. e172470, http://dx.doi.org/10.1172/jci.insight.172470
,2023, 'B Cell Signatures and Antibody Imprinting Define HCV Reinfection Outcome', , http://dx.doi.org/10.2139/ssrn.4418620
,2022, 'Early microbial exposure shapes adult immunity by altering CD8+ T cell development', Proceedings of the National Academy of Sciences of the United States of America, 119, pp. e2212548119, http://dx.doi.org/10.1073/pnas.2212548119
,2022, 'Population heterogeneity in Plasmodium vivax relapse risk', PLoS Neglected Tropical Diseases, 16, http://dx.doi.org/10.1371/journal.pntd.0010990
,2022, 'Similarly efficacious anti-malarial drugs SJ733 and pyronaridine differ in their ability to remove circulating parasites in mice', Malaria Journal, 21, pp. 49, http://dx.doi.org/10.1186/s12936-022-04075-z
,2022, 'Nice and slow make the germinal centers go: measured and escalating antigen delivery enhance durability and quality of humoral immune responses against HIV-1', Immunology and Cell Biology, 100, pp. 750 - 752, http://dx.doi.org/10.1111/imcb.12596
,2022, 'The magnitude and timing of recalled immunity after breakthrough infection is shaped by SARS-CoV-2 variants', Immunity, 55, pp. 1316 - 1326.e4, http://dx.doi.org/10.1016/j.immuni.2022.05.018
,2022, 'Parasite Viability as a Measure of in Vivo Drug Activity in Preclinical and Early Clinical Antimalarial Drug Assessment', Antimicrobial Agents and Chemotherapy, 66, pp. e00114 - e00122, http://dx.doi.org/10.1128/aac.00114-22
,2022, 'Relating in Vitro Neutralization Level and Protection in the CVnCoV (CUREVAC) Trial', Clinical Infectious Diseases, 75, pp. E878 - E879, http://dx.doi.org/10.1093/cid/ciac075
,2022, 'Disentangling the relative importance of T cell responses in COVID-19: leading actors or supporting cast?', Nature Reviews Immunology, 22, pp. 387 - 397, http://dx.doi.org/10.1038/s41577-022-00716-1
,2022, 'Effect of novel antimalarial ZY-19489 on Plasmodium falciparum viability in a volunteer infection study', The Lancet Infectious Diseases, 22, pp. 760 - 761, http://dx.doi.org/10.1016/S1473-3099(22)00294-8
,2022, 'Platform for isolation and characterization of SARS-CoV-2 variants enables rapid characterization of Omicron in Australia', Nature Microbiology, 7, pp. 896 - 908, http://dx.doi.org/10.1038/s41564-022-01135-7
,2022, 'Efficient recall of Omicron-reactive B cell memory after a third dose of SARS-CoV-2 mRNA vaccine', Cell, 185, pp. 1875 - 1887.e8, http://dx.doi.org/10.1016/j.cell.2022.04.009
,